From: Cataract and glaucoma combined surgery: XEN® gel stent versus nonpenetrating deep sclerectomy, a pilot study
XEN (n = 45 eyes)
NPDS (n = 53 eyes)
p-value
Postoperative VA, LogMAR mean ± SD
0.07 ± 0.13
0.12 ± 0.17
0.12
VA evolution, LogMAR ± SD
−0.21 ± 0.17
−0.24 ± 0.31
0.65